Skip to main content
MedicHelpLine
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONGeneric

TETRACYN

TETRACYCLINE HYDROCHLORIDE

Standard Dose
250MG/VIAL
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview TETRACYN is listed in Drugs@FDA under application 060096 (ANDA).

Marketing status: Discontinued Active ingredient TETRACYCLINE HYDROCHLORIDE Form and strength INJECTABLE;INJECTION - 250MG/VIAL Sponsor PFIZER Submission history See approval history documents.

Structured Monograph

Clinical summary

Approval overview TETRACYN is listed in Drugs@FDA under application 060096 (ANDA). Marketing status: Discontinued Active ingredient TETRACYCLINE HYDROCHLORIDE Form and strength INJECTABLE;INJECTION - 250MG/VIAL Sponsor PFIZER Submission history See approval history documents.

Monitoring

  • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.
TETRACYN (TETRACYCLINE HYDROCHLORIDE) | Drug Monograph | MedicHelpline